Psoriasis is usually treated as a skin condition, but new genetic data suggests hormone regulation may play a larger role than we recognize. More than 82% of the psoriasis group in our database carried a CYP19A1 pattern linked to aromatase and local estrogen activity, compared with about 40.6% of everyone else. This piece breaks down what CYP19A1 does, why hormonal transitions can affect psoriasis, and where nutrients like vitamin D, zinc, and omega-3s fit into the picture.
Go to comment (1)A Hormone-Related Genetic Pattern May Be Linked to Psoriasis
New data from Molecular Health Co. points to a possible hormone-sensitive subtype
Psoriasis is often described as a skin condition. Anyone living with it knows it can affect much more than the skin.
It may involve painful plaques, cracking, itching, fatigue, inflammation, joint pain, or psoriatic arthritis. Some people experience mild symptoms. Others feel the effects throughout their entire body.
Many spend years trying creams, medications, elimination diets, and supplements without understanding why their immune system became so reactive in the first place.
After analyzing genetic and health data through Molecular Health Co., we found a pattern that may help explain one possible biological subtype of psoriasis.
82%
of the psoriasis group carried one of two CYP19A1 genetic patterns
compared with about 40.6% of the rest of the database
This pattern appeared about twice as often in people reporting psoriasis. The estimated odds were also substantially higher in the psoriasis group.
What this does and doesn't mean: This doesn't prove CYP19A1 causes psoriasis. It does suggest hormone regulation may play a larger role in some people than we currently recognize.
What Is CYP19A1?
CYP19A1 is the gene that produces an enzyme called aromatase. Aromatase converts certain androgens into estrogens.
- Testosterone can be converted into estradiol
- Androstenedione can be converted into estrone
Most people associate estrogen production with the ovaries. Aromatase is active throughout the body, including in:
- Skin
- Adipose tissue
- Bone
- Blood vessels
- Brain
- Muscle
- Reproductive tissues
Hormone production and regulation don't only happen in the reproductive organs. Individual tissues can create and regulate their own local estrogen activity. Local hormone signaling can influence inflammation, immune activity, tissue repair, and the way skin cells grow.
Why Could CYP19A1 Matter in Psoriasis?
Psoriasis develops through abnormal communication between the immune system and skin cells. Immune signals tell skin cells to grow and divide too quickly. Those cells accumulate on the surface before older cells have had time to shed. This creates the thick, inflamed plaques associated with psoriasis.
Estrogen influences many of the same systems involved in that process:
- Keratinocyte growth
- Skin-cell differentiation
- Immune regulation
- Skin-barrier integrity
- Wound healing
- Blood-vessel growth
- Cytokine signaling
- Oxidative stress control
Keratinocytes are the primary cells that make up the outer layer of skin. In psoriasis, these cells divide too rapidly and receive abnormal inflammatory signals. Changes in local estrogen activity could influence how strongly those skin cells respond.
Estrogen Is an Immune-Regulating Hormone
Estrogen is often discussed only as a reproductive hormone. Its role extends throughout the body, influencing immune-cell behavior, brain function, bone remodeling, blood-vessel tone, collagen production, skin hydration, mitochondrial function, antioxidant defenses, and inflammatory signaling.
Its immune effects are complex. The response can vary based on hormone concentration, tissue type, estrogen receptor activity, age, sex, menstrual status, pregnancy, menopause, genetics, and existing inflammation.
This helps explain why the same hormone may calm inflammation in one situation and intensify immune activity in another. Hormone biology is highly individualized.
Why Hormonal Transitions Can Affect Psoriasis
Many people notice their psoriasis changes during periods of hormonal transition. Symptoms may begin or worsen during puberty, menstrual changes, pregnancy, the postpartum period, perimenopause, menopause, or hormone therapy.
Some women experience improvement during pregnancy, followed by a strong postpartum flare. Others notice their psoriasis worsens as estrogen declines during perimenopause or menopause. Some people notice flares around specific points in their menstrual cycle.
These changes suggest hormone signaling can alter the inflammatory environment of the skin. The CYP19A1 pattern found in the database may help identify people who are more sensitive to those changes.
Local Hormone Activity Can Differ From Blood Tests
One of the most important parts of this finding is understanding the difference between blood hormone levels and local tissue hormone activity.
Someone may have normal estrogen on a blood test while hormone signaling inside the skin behaves differently. The skin contains the enzymes and receptors needed to respond to and metabolize hormones locally. Adipose tissue also contains aromatase.
Body composition, inflammation, age, stress, and genetics can all influence local hormone production. A standard blood test may not fully reflect what's happening inside the skin. This could be one reason some people have strong hormone-related symptoms despite normal laboratory results.
What Do These CYP19A1 Variants Do?
Current research doesn't allow us to confidently label these variants as simply increasing or decreasing aromatase. That would be an oversimplification.
Genetic variants may influence gene regulation, messenger RNA stability, enzyme expression, tissue-specific activity, response to inflammation, and interaction with nearby variants.
The rs4646 variant is located in a regulatory region of CYP19A1. This region may influence how the gene's message is processed or stabilized after transcription. The functional significance of rs1061472 is less established. It may act as a regulatory marker or may travel with other nearby CYP19A1 variants.
The most accurate interpretation is that these genotypes may identify a CYP19A1 regulatory pattern. They don't tell us on their own whether someone has high estrogen, low estrogen, or excessive aromatase activity.
Could This Represent a Hormonal Psoriasis Subtype?
Psoriasis may not have one single biological pathway. Two people can receive the same diagnosis while having very different underlying physiology.
- One person may have stronger gut and immune involvement
- Another may have substantial oxidative stress
- Another may have metabolic dysfunction or insulin resistance
- Another may have stronger hormonal triggers
- Another may have a combination of several of these
The CYP19A1 pattern could represent one possible hormone-sensitive psoriasis subtype, more relevant in people whose symptoms change with menstrual cycles, pregnancy, postpartum shifts, menopause, weight changes, stress, hormone medications, or changes in inflammatory health.
Psoriasis Often Appears With Other Health Concerns
The psoriasis group in the database frequently reported concerns beyond the skin:
- Fatigue
- Arthritis and psoriatic arthritis
- Anxiety and depression
- Joint pain
- Gluten-related symptoms
- Insomnia
- Hormonal concerns
- Histamine problems
- Hypothyroidism and Hashimoto's disease
- Irritable bowel syndrome and colitis
- Eczema
These overlapping symptoms don't mean CYP19A1 caused them. They show that psoriasis often occurs within a broader inflammatory and metabolic picture. Inflammation can affect the skin, joints, nervous system, thyroid, gut, and energy production at the same time.
The Connection With Psoriatic Arthritis
Psoriatic arthritis is an inflammatory condition that can develop in people with psoriasis. It may cause joint pain, swelling, morning stiffness, tendon pain, back pain, finger or toe swelling, reduced mobility, and fatigue.
Hormones influence bone, cartilage, tendons, immune cells, and connective tissue. CYP19A1 may therefore be relevant to both skin inflammation and joint involvement. Future analysis should compare people with skin-only psoriasis to those with psoriatic arthritis.
The Role of Adipose Tissue
Adipose tissue is metabolically active. It produces hormones, cytokines, and inflammatory signals, and it also contains aromatase.
Higher levels of adipose tissue may increase peripheral estrogen production in some people. Adipose tissue can also increase inflammatory cytokines that contribute to psoriasis. This doesn't mean body weight causes psoriasis. It means adipose tissue may become part of the biological environment influencing hormone signaling and inflammation. Genetics may alter how strongly someone responds to that environment.
Stress, Hormones, and Skin Inflammation
Chronic stress can affect psoriasis through several pathways. Stress hormones influence immune-cell activity, blood sugar, sleep, histamine release, inflammatory cytokines, hormone metabolism, and skin-barrier repair.
When stress becomes chronic, the body may have greater difficulty resolving inflammation. Poor sleep can increase that burden further. Someone with genetic differences in hormone regulation may be more sensitive to those changes.
Where Nutrients Fit Into the Picture
A CYP19A1 variant doesn't point to one single supplement. Genes work within larger nutrient-dependent pathways. A more useful approach is to support the physiology surrounding skin repair, immune regulation, hormone metabolism, and inflammation.
Vitamin D
Vitamin D helps regulate keratinocyte growth, skin-cell maturation, immune-cell activity, inflammatory signaling, and bone health. Topical vitamin D analogues are already used in conventional psoriasis treatment because of their effects on abnormal skin-cell growth. Vitamin D status is worth assessing rather than guessing.
Zinc
Zinc supports wound healing, skin repair, immune balance, antioxidant defense, hormone-receptor function, and protein synthesis. Low zinc intake or poor absorption may contribute to slower healing and impaired skin-barrier function. People with digestive conditions or highly restrictive diets may be more vulnerable to low zinc status.
Magnesium
Magnesium participates in hundreds of enzymatic reactions, supporting vitamin D metabolism, stress regulation, sleep, glucose control, mitochondrial energy, and inflammatory regulation. Magnesium may be especially important when psoriasis occurs alongside insulin resistance, high stress, poor sleep, or muscle tension.
Omega-3 Fatty Acids
EPA and DHA help the body produce compounds involved in resolving inflammation, supporting skin-barrier health, cell-membrane structure, vascular function, and immune regulation. Genetic variants in FADS1 and FADS2 can affect how efficiently someone converts plant-based omega-3 fats into EPA and DHA. This is why two people can follow the same diet and still have very different fatty-acid status.
Vitamin C
Vitamin C supports collagen production, wound healing, antioxidant protection, immune regulation, connective tissue, and skin-barrier repair. Chronic inflammation can increase antioxidant demand, so vitamin C requirements may vary depending on inflammation, stress, diet, and genetics.
Riboflavin and Niacinamide
Riboflavin and niacinamide support cellular energy production and redox balance. Skin cells divide rapidly and require substantial energy. These nutrients help enzymes involved in mitochondrial function, antioxidant recycling, cellular repair, fat metabolism, and inflammatory regulation. They support the environment in which enzymes function. They don't directly change CYP19A1 genetics.
Protein and Amino Acids
Skin repair requires adequate protein. The body uses amino acids to produce collagen, keratin, glutathione, enzymes, immune proteins, and connective tissue. Highly restrictive diets can sometimes reduce the nutrients needed for tissue repair. Food triggers may matter, but the body still needs enough raw material to rebuild the skin.
What this pattern doesn't mean: It doesn't mean everyone with these variants will develop psoriasis. It doesn't mean estrogen is always too high or too low, that aromatase should be blocked, that hormone medication should be changed, that one supplement will resolve psoriasis, or that genetics are the only factor involved. These variants are also present in people who don't report psoriasis. Their importance lies in how much more frequently they appeared in the psoriasis group.
What We Need to Study Next
- Is it stronger in women than men?
- Is it more common in psoriatic arthritis?
- Does it cluster with menopause-related psoriasis?
- Is it connected with postpartum flares?
- Does body composition affect the association?
- Does it interact with ESR1 or ESR2 estrogen-receptor variants?
- Does it become stronger alongside IL6, TNF, or IL23R patterns?
- Does it appear in other autoimmune skin conditions?
- Do carriers respond differently to specific nutrients?
Larger samples will help determine how reliable and specific the pattern is.
Why This Matters for Personalized Health
Psoriasis is usually treated according to the visible diagnosis. Genetic data allows us to examine the pathways underneath that diagnosis. Two people may both have psoriasis while needing very different types of support.
One may need stronger attention to hormone metabolism. Another may need deeper work around metabolic inflammation. Another may have significant gut, histamine, or nutrient-transport issues. Another may have stronger oxidative stress and cell-membrane dysfunction.
The diagnosis gives us the name of the condition. The genetics may help explain the physiology behind it.
Psoriasis may involve the skin, but the biology reaches far beyond it. Hormones, immune signaling, inflammation, nutrient status, cell membranes, stress physiology, and genetics all influence how the skin functions. Understanding those layers may eventually help identify why each person's immune system began reacting in the first place.
We May Have Found a Hormone-Related Genetic Pattern in Psoriasis
Comment (1)
Hello, thank you for this very informative article. I am diagnosed with psoriatic arthritis, it didn’t activate until I was in my 60’s, ( now middle 70’s) I am a ferternal twin, my twin had no symptoms, never had children, and is overall healthy and has no medical conditions.